tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market
MDGL
Madrigal Pharmaceuticals
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Madrigal Pharmaceuticals (MDGL) Stock News & Sentiment

Compare
1,176 Followers
Madrigal’s Earnings Call Highlights Strong Growth
Premium
Company Announcements
Madrigal’s Earnings Call Highlights Strong Growth
5d ago
MDGL
Cautious Outlook on Madrigal Pharmaceuticals Amid Potential Overvaluation and Competitive Pressures
Premium
Ratings
Cautious Outlook on Madrigal Pharmaceuticals Amid Potential Overvaluation and Competitive Pressures
5d ago
MDGL
Madrigal’s Financial Vulnerability: Overreliance on Specialty Pharmacies Threatens Revenue Stability
Premium
Company Announcements
Madrigal’s Financial Vulnerability: Overreliance on Specialty Pharmacies Threatens Revenue Stability
5d ago
MDGL
Madrigal Pharmaceuticals Reports Strong Rezdiffra Sales
Premium
Company Announcements
Madrigal Pharmaceuticals Reports Strong Rezdiffra Sales
6d ago
MDGL
Buy Rating for Madrigal Pharmaceuticals Driven by Strong Financials and Promising Clinical Trial Results
Premium
Ratings
Buy Rating for Madrigal Pharmaceuticals Driven by Strong Financials and Promising Clinical Trial Results
6d ago
MDGL
Madrigal (MDGL) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Madrigal (MDGL) Q4 Earnings Cheat Sheet
8d ago
MDGL
Madrigal Pharmaceuticals’ Treatment Could Be a Blockbuster in the Making
Premium
Market News
Madrigal Pharmaceuticals’ Treatment Could Be a Blockbuster in the Making
1M ago
MDGL
More MDGL News >

MDGL News on the Web

Madrigal’s Earnings Call Highlights Strong Growth
TipRanks News
Neutral
We're Not Worried About Madrigal Pharmaceuticals' Cash Burn
Yahoo Finance
Neutral
Madrigal Pharmaceuticals Inc Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...
Yahoo Finance
Neutral
Q4 2024 Madrigal Pharmaceuticals Inc Earnings Call
Yahoo Finance
Neutral
JMP Securities Reaffirms Their Buy Rating on Madrigal Pharmaceuticals (MDGL)
TipRanks News
Neutral
Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing Potential Benefit of Rezdiffra For Compensated Fatty Liver Cirrhosis
Yahoo Finance
Neutral
Madrigal Pharmaceuticals Phase 3 data 'encouraging,' says UBS
The Fly
Neutral
Madrigal Unveils Encouraging Two-Year Results For Rezdiffra In Compensated MASH Cirrhosis
rttnews
Neutral

News Score - Last 7 Days

Neutral
MDGL
Sector Average
Media Buzz
This Week13 articles
Weekly Average4.5 articles
News Sentiment
This Week50%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MDGL’s Media Buzz Sentiment?
13 articles about MDGL were published this week. In an average week, 4.5 articles are published.
    What is MDGL’s weekly average amount of articles?
    In an average week, 4.5 articles about MDGL are published.
      What is MDGL’s News Sentiment?
      50% of articles about MDGL were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        CCCCC4 Therapeutics
        JAZZJazz Pharmaceuticals
        CTECConvaTec
        CORTCorcept Therapeutics
        RCKTRocket Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing